May 6 |
Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
May 3 |
How Novo-Catalent Deal Affects Halozyme (HALO)?
|
Apr 30 |
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
|
Apr 25 |
Mahesh Krishnan Elected to Halozyme's Board of Directors
|
Apr 25 |
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
|
Apr 24 |
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
|
Apr 23 |
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
Apr 23 |
Halozyme to Report First Quarter 2024 Financial and Operating Results
|
Apr 18 |
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
|
Apr 18 |
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
|